1. A 42-year-old wom an undergoing heart transplant received mycophenolate m ofetil, cyclosporine, and prednisone before surgery. Which of the follow ing statem ents best explains w hy mycophenolate m...

1. A 42-year-old wom an undergoing heart transplant received mycophenolate m ofetil, cyclosporine, and prednisone before surgery. Which of the follow ing statem ents best explains w hy mycophenolate m ofetil is currently used instead of azathioprine to prevent rejection in solid organ transplantation? A. Its im m unosuppressive activity is de nitely superior to that of azathioprine. B. It has signi cantly few er adverse e ects than azathioprine. C. It has drastically reduced the risk of graft-versus-host disease. D. It selectively inhibits m acrophage-m ediated production of several interleukins. E. It selectively inhibits antigen recognition by antigenpresenting cells.